BASF in spray drying co-operation with GEA Niro

Published: 11-Feb-2010 Featured companies: GEA Pharma and Healthcare
Manufacturing Ingredients Research & Development

BASF has signed an agreement with GEA Niro, which will allow BASF to make cGMP (current Good Manufacturing Practice) spray drying tests and pilot productions of active pharmaceutical ingredients (APIs) at GEA Niro\'s pharma test station in Copenhagen, Denmark.

BASF has signed an agreement with GEA Niro, which will allow BASF to make cGMP (current Good Manufacturing Practice) spray drying tests and pilot productions of active pharmaceutical ingredients (APIs) at GEA Niro's pharma test station in Copenhagen, Denmark. This test station is said to be one of the most advanced and versatile cGMP spray drying facilities worldwide.

Through the cooperation, BASF's Pharma Ingredients & Services division will add spray drying of APIs and formulations to its custom synthesis services for small molecules for the pharmaceutical industry.

Folker Ruchatz, BASF's director of global business management custom synthesis, said: "Teaming up with GEA Niro gives us access to a superior facility, and by working with the leading supplier of spray drying technology worldwide, we can provide the best solutions to our customers' needs sustainably."




Featured companies

GEA is a leading provider of process technology and packaging solutions for the pharmaceutical, biopharmaceutical, biotechnology and nutraceutical industries. Our portfolio...
  • Companies:
  • BASF Personal Care and Nutrition GmbH
See more

You may also like

Manufacturing

Aseptic spray drying: Transforming biotherapeutics for a new era

Read more
With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications

Trending Articles

  1. Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025 The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
  2. Merck Life Science announces closure of Arklow facility Merck has said it will close the plant in Co Wicklow, Ireland, by the end of 2028, with the loss of 100 jobs
  3. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
  4. What to expect from a regulatory inspection NSF’s expert guide outlines key expectations, common pitfalls and strategies for lasting inspection readiness
  5. Hovione completes $100m investment cycle for expansion of US manufacturing campus The investment into the New Jersey facility will more than double capacity for spray drying

Relevant companies

See more

You may also like

Manufacturing

Aseptic spray drying: Transforming biotherapeutics for a new era

With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
Manufacturing

Almac expands bioavailability capabilities to address a critical need in drug development

Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
Manufacturing

Sustainability that performs: how GEA is building a better future for pharma

By embedding ESG principles into pharmaceutical manufacturing, GEA is delivering measurable sustainability performance without compromising compliance or productivity
Manufacturing

GEA raises guidance following strong H1 performance

Revised forecast reflects improved margins, robust order intake and efficiency gains
Manufacturing

First product chambers placed in GEA's "Factory of the Future"

Responding to the growing demand for freeze-drying systems, GEA Pharma & Healthcare is investing €80m in the construction of a pharmaceutical technology centre in Elsdorf (North Rhine-Westphalia)
Manufacturing

A forward-thinking approach to reducing downtime and costs in the pharmaceutical industry

Implementing predictive maintenance and a lifecycle package can significantly reduce both downtime and costs in the pharmaceutical industry, emphasises Benoit Dehaene from GEA Pharma & Healthcare
Subscribe now